Dolby Laboratories
(DLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 183,240 | 208,720 | 190,302 | 265,134 | 310,582 |
| Depreciation Amortization | 78,295 | 62,676 | 63,479 | 61,016 | 61,082 |
| Income taxes - deferred | -14,484 | -6,696 | -19,642 | 1,208 | 6,784 |
| Accounts receivable | -7,008 | 10,165 | -53,639 | 18,831 | -8,514 |
| Other Working Capital | 18,864 | 30,661 | -20,291 | 15,843 | -10,362 |
| Other Operating Activity | 50,470 | 56,021 | 116,292 | 27,889 | 44,116 |
| Operating Cash Flow | $309,377 | $361,547 | $276,501 | $389,921 | $403,688 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -157,526 | -75,363 | -26,208 | -165,274 | -43,795 |
| Net Acquisitions | -93,516 | N/A | N/A | -12,521 | -3,350 |
| Purchase Of Investment | -392,936 | -389,282 | -485,370 | -611,211 | -619,238 |
| Sale Of Investment | 451,377 | 296,618 | 692,493 | 594,677 | 429,681 |
| Purchase Sale Intangibles | -37,416 | -37,950 | -4,050 | -350 | 0 |
| Other Investing Activity | -10,994 | -36,917 | -5,890 | -474 | 0 |
| Investing Cash Flow | $-203,595 | $-204,944 | $175,025 | $-194,803 | $-236,702 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -79 | -518 | 0 |
| Common Stock Issued | 28,627 | 33,373 | 15,958 | 17,386 | 27,918 |
| Common Stock Repurchased | -107,349 | -56,028 | -82,245 | -268,203 | -192,410 |
| Dividend Paid | -41,018 | N/A | -408,206 | N/A | N/A |
| Other Financing Activity | -18,779 | -17,925 | -13,392 | -2,983 | 1,994 |
| Financing Cash Flow | $-138,519 | $-40,580 | $-487,964 | $-254,318 | $-162,498 |
| Exchange Rate Effect | -3,809 | -1,948 | -1,765 | 288 | 1,163 |
| Beginning Cash Position | 568,472 | 454,397 | 492,600 | 551,512 | 545,861 |
| End Cash Position | 531,926 | 568,472 | 454,397 | 492,600 | 551,512 |
| Net Cash Flow | $-36,546 | $114,075 | $-38,203 | $-58,912 | $5,651 |
| Free Cash Flow | |||||
| Operating Cash Flow | 309,377 | 361,547 | 276,501 | 389,921 | 403,688 |
| Capital Expenditure | -157,526 | -75,363 | -26,711 | -167,349 | -47,362 |
| Free Cash Flow | 151,851 | 286,184 | 249,790 | 222,572 | 356,326 |